Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02011464 · ClinicalTrials.gov registry record · Phase 4
Evaluation Exparel Delivered in Knee Replacement
A Phase 4 study, sponsored by Maimonides Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT02011464 is a Phase 4 study that has completed, run by Maimonides Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT02011464, a Phase 4 study, has completed, sponsored by Maimonides Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
Pain control after knee replacement requires analgesia to both the top (anterior) and bottom (posterior) portion of the the knee. Presently we use a nerve block for the anterior portion. The investigators want to to examine if giving Exparel into the posterior portion will give better pain relief. Hypothesis: There is no difference in, the use of analgesics or the length and quality of analgesia and no decrease in the time to be able to accomplish simple to complex knee movements using Exparel infiltration when compared to controls.
Interventions
- OTHER Saline
- DRUG Exparel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02011464
The ClinicalTrials.gov registry entry for NCT02011464 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maimonides Medical Center, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT02011464 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02011464 about?
NCT02011464 is a clinical study titled "Evaluation Exparel Delivered in Knee Replacement". Pain control after knee replacement requires analgesia to both the top (anterior) and bottom (posterior) portion of the the knee. Presently we use a nerve block for the anterior portion. The investigators want to to examine if giving Exparel into the posterior portion will give better pain relief. ...
What is the current status of trial NCT02011464?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2013-12. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02011464?
The interventions under investigation include: Saline (OTHER), Exparel (DRUG).
Who is sponsoring clinical trial NCT02011464?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.